Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Key facts

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Principal Investigator

Yingren Zhao, Professor

First Affiliated Hospital of Xian Jiaotong University

Intervention

Peg IFN-α-2b(drug)

Enrollment

1500 enrolled

Eligibility

18-70 years · All sexes

Timeline

2025 – 2032

Study locations (1)

• First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Cryptogenic organizing pneumonia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07131527
  Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy
  Sohag University
• ACTIVE NOT RECRUITINGNCT06203964
  Organizing Pneumonia in Lung Transplant Recipients, a Restrospective Exploratory Study (OPIL-Study)
  University of Zurich
• RECRUITINGNCT04431479
  Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
  Fred Hutchinson Cancer Center

See all trials for Cryptogenic organizing pneumonia →